Your browser doesn't support javascript.
loading
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
Camacho, Jorge; Giménez, Estela; Albert, Eliseo; Zulaica, Joao; Álvarez-Rodríguez, Beatriz; Torres, Ignacio; Rusu, Luciana; Burgos, Javier S; Peiró, Salvador; Vanaclocha, Hermelinda; Limón, Ramón; Alcaraz, María Jesús; Sánchez-Payá, José; Díez-Domingo, Javier; Comas, Iñaki; Gonzáles-Candelas, Fernando; Geller, Ron; Navarro, David.
Afiliação
  • Camacho J; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Giménez E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Albert E; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Zulaica J; Institute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
  • Álvarez-Rodríguez B; Institute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
  • Torres I; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Rusu L; Institute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
  • Burgos JS; General Directorate of Research and Healthcare Supervision, Department of Health, Valencia Government, Valencia, Spain.
  • Peiró S; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
  • Vanaclocha H; General Directorate of Public Health, Department of Health, Valencia Government, Valencia, Spain.
  • Limón R; General Directorate of Healthcare. Department of Health, Valencian Government, Valencia, Spain.
  • Alcaraz MJ; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
  • Sánchez-Payá J; Preventive Medicine Service, Alicante General and University Hospital, Alicante, Spain.
  • Díez-Domingo J; Alicante Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
  • Comas I; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO), Valencia, Spain.
  • Gonzáles-Candelas F; Biomedicine Institute of Valencia, Spanish Research Council (CSIC), Valencia, Spain.
  • Geller R; CIBER in Epidemiology and Public Health, Spain; Joint Research Unit "Infection and Public Health" FISABIO-University of Valencia, Valencia, Spain.
  • Navarro D; Institute for Integrative Systems Biology (I2SysBio), University of Valencia-CSIC, Valencia, Spain.
J Med Virol ; 95(1): e28284, 2023 01.
Article em En | MEDLINE | ID: mdl-36333837
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article